I dette forsøg havde 87% af patienterne sygdom, som var IHC 3+, og 95% af de inkluderede patienter havde sygdom, som var IHC3+ og/ eller patienterne var FISH positive.
In this trial, 87% of patients had disease that was IHC 3+, and 95% of patients entered had disease that was IHC 3+ and/ or FISH positive.